Here is the latest stock price and chart of IPCA Labs. For more details, see the IPCA Labs company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report. Since small-cap stocks interest you, here's a proven approach on investing in small-cap stocks.
Get Details: We are Bullish on These 3 Little-known Stocks
Live BSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,045.95 | Open (Rs) 2,054.25 | High (Rs) 2,065.00 | Low (Rs) 2,012.40 |
% Change-0.40 | Volume 17,172 | Value (Rs) 34,969,258 | 52-Week H/L 2,455.55 / 1,162.00 |
Live NSE Quotes | Jan 22, 2021 (Close) | ||
---|---|---|---|
Price (Rs)2,044.65 | Open (Rs) 2,055.00 | High (Rs) 2,067.00 | Low (Rs) 2,012.80 |
% Change-0.36 | Volume 300,910 | Value (Rs) 615,255,632 | 52-Week H/L 2,460.00 / 1,163.90 |
Change | |||||
---|---|---|---|---|---|
1 Day -0.40% | 1 Month -7.21% | 3 Months -5.00% | 1 Year 66.43% | 5 Years (CAGR)* 26.09% | 10 Years (CAGR)* 20.33% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 77.18 | P/E Ratio (x) 26.51 | Market Cap (Rs m) 258,196.84 | P/BV (x) 8.27 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
IPCA LABS last traded price was down 0.4% to Rs 2,046.0 on the BSE. On the NSE, IPCA LABS last traded price was down 0.4% to Rs 2,044.7. The total volume of shares traded was 0.3 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 1.2%. And the benchmark S&P BSE SENSEX was at 48,878.5 (down 1.5%).
Over the last 30 days, the IPCA LABS share price is down 7.8%. And over the last one year, IPCA LABS share price is up 67.1%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.
For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.
More Views on NewsWere you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...
In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.
Our ace stock picker is ready to capitalise on a big growth opportunity.
The pandemic failed to thwart Richa's investing success formula for 2020.
More